Free Trial
NASDAQ:GLSI

Greenwich LifeSciences (GLSI) Stock Price, News & Analysis

Greenwich LifeSciences logo
$10.91 +0.26 (+2.44%)
Closing price 04:00 PM Eastern
Extended Trading
$10.83 -0.08 (-0.72%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Greenwich LifeSciences Stock (NASDAQ:GLSI)

Advanced

Key Stats

Today's Range
$10.66
$11.13
50-Day Range
$9.95
$12.49
52-Week Range
$8.06
$15.47
Volume
46,838 shs
Average Volume
90,012 shs
Market Capitalization
$148.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.00
Consensus Rating
Hold

Company Overview

Greenwich LifeSciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

GLSI MarketRank™: 

Greenwich LifeSciences scored higher than 23% of companies evaluated by MarketBeat, and ranked 847th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Greenwich LifeSciences has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Greenwich LifeSciences has a consensus price target of $42.00, representing about 285.0% upside from its current price of $10.91.

  • Amount of Analyst Coverage

    Greenwich LifeSciences has only been the subject of 2 research reports in the past 90 days.

  • Read more about Greenwich LifeSciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Greenwich LifeSciences are expected to decrease in the coming year, from ($0.80) to ($0.81) per share.

  • Price to Book Value per Share Ratio

    Greenwich LifeSciences has a P/B Ratio of 57.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Greenwich LifeSciences' valuation and earnings.
  • Percentage of Shares Shorted

    20.13% of the float of Greenwich LifeSciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Greenwich LifeSciences has a short interest ratio ("days to cover") of 18.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Greenwich LifeSciences has recently increased by 14.95%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Greenwich LifeSciences does not currently pay a dividend.

  • Dividend Growth

    Greenwich LifeSciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    20.13% of the float of Greenwich LifeSciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Greenwich LifeSciences has a short interest ratio ("days to cover") of 18.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Greenwich LifeSciences has recently increased by 14.95%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Greenwich LifeSciences has a news sentiment score of -0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Greenwich LifeSciences this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for GLSI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Greenwich LifeSciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Greenwich LifeSciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    51.67% of the stock of Greenwich LifeSciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.16% of the stock of Greenwich LifeSciences is held by institutions.

  • Read more about Greenwich LifeSciences' insider trading history.
Receive GLSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GLSI Stock News Headlines

Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
See More Headlines

GLSI Stock Analysis - Frequently Asked Questions

Greenwich LifeSciences' stock was trading at $11.23 at the beginning of 2025. Since then, GLSI shares have decreased by 2.8% and is now trading at $10.91.

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) posted its earnings results on Thursday, August, 14th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by $0.06.

Greenwich LifeSciences (GLSI) raised $7 million in an initial public offering on Friday, September 25th 2020. The company issued 1,300,000 shares at a price of $5.75 per share. Aegis Capital served as the underwriter for the IPO.

Shares of GLSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Greenwich LifeSciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/14/2025
Today
10/03/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GLSI
CIK
1799788
Fax
N/A
Employees
3
Year Founded
2006

Price Target and Rating

High Price Target
$45.00
Low Price Target
$39.00
Potential Upside/Downside
+289.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-700.90%
Return on Assets
-455.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.85
Quick Ratio
1.85

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
56.81

Miscellaneous

Outstanding Shares
13,630,000
Free Float
6,587,000
Market Cap
$147.12 million
Optionable
Not Optionable
Beta
1.62

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GLSI) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners